|
Çѱ¹MSD À¯ÇÑȸ»ç |
±¸¸ÅºÎ Procurement specialist ¸ðÁý
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ý»êÁö¿ø/¹°·ù/±¸¸Å |
3³â¡è |
ä¿ë½Ã |
11.08 |
|
|
³ª¿ìÇÇÇà |
±¹³»´ë±â¾÷-¹ÙÀÌ¿À½Ã¹Ð·¯ ÇØ¿Ü RA & ¶óÀ̼¾½Ì
¼¿ï Áß±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
3³â¡è |
ä¿ë½Ã |
04.02 |
|
|
Çѱ¹MSD µ¿¹°¾àÇ° |
[Çѱ¹MSDµ¿¹°¾àÇ°]-Swine Key Account Manager
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
3³â¡è |
ä¿ë½Ã |
05.13 |
|
|
(ÁÖ)¸ÞµðÇïÇÁ¶óÀÎ |
ÀÎÇã°¡»ç¾÷ºÎ ÀÇ·á±â±â»ç¾÷ÆÀ ½ÅÀÔ/°æ·Â ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
2³â¡è |
»ó½Ãä¿ë |
01.03 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
Oncology MSL 2¸í ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
10.31 |
|
|
Çѱ¹¿¥¿¡½ºµð ÁÖ½Äȸ»ç |
[Çѱ¹MSDµ¿¹°¾àÇ°]-Technical Marketing Manager-¹Ý·Áµ¿¹°,
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
08.13 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
Çѱ¹MSD CRA ´Ù¼ö ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
09.04 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
(Sr.)CRA ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
07.24 |
|
|
Çѱ¹¿¥¿¡½ºµð ÁÖ½Äȸ»ç |
[Çѱ¹MSD] MSL-ID/Vaccine
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
08.13 |
|
|
½Å¶óÁ¨(ÁÖ) |
Clinical DeliveryÆÀ¿ø(CDA) ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
12.11 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
(Sr.)RA Specialist 2¸í ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
05.13 |
|
|
(ÁÖ)¸ÞµðÇïÇÁ¶óÀÎ |
Clinical QA Team(Ç°Áúº¸Áõ) °æ·Â»ç¿ø ¸ðÁý
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
2³â¡è |
ä¿ë½Ã |
11.17 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
[Çѱ¹MSD]Business practice officer(Compliance officer)
¼¿ï Áß±¸, ¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
2³â¡è |
ä¿ë½Ã |
05.10 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
(Sr.)CRA ´Ù¼ö ¸ðÁý
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
2³â¡è |
ä¿ë½Ã |
05.21 |
|
|
(ÁÖ)¸ÞµðÇïÇÁ¶óÀÎ |
Clinical QA Team(Ç°Áúº¸Áõ) °æ·Â»ç¿ø/ÆÀÀå ¸ðÁý
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
2³â¡è |
ä¿ë½Ã |
12.01 |
|